
About The Derma Co
The Derma Co is a publicly listed company based in Gurugram (India) founded in 2019. A brand specializing in skin care products. It operates on a B2C model. The company has 998 employees. Its website thedermaco.com draws about 3 million monthly visits. Its Indian entity Honasa Consumer Limited reported revenue of βΉ2,476 Cr. Its focus areas include Consumer Goods, Personal Care, Skin Care and Products. Its competitors include Foxtale, World of Asaya and Conscious Chemist; 3 of its 3 listed competitors have raised funding.
Company details
The Derma Co a brand specializing in skin care products, focusing on producing consumer products, providing personal care products, skin care, and products. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Gurugram, India
- Employees 998
- Stage Public
- SectorsConsumer
- Website category Lifestyle · Beauty and Cosmetics
- Website thedermaco.com
- Social X Facebook
- Legal Name Honasa Consumer Limited
- Date of Incorporation 16 Sep, 2016
- Jurisdiction New Delhi, Delhi, India
- Market Cap₹15,794 Cr
HONASA · NSE
- Share Price₹484.35
+0.06% today
- Revenue₹2,392 Cr
FY 2025-26 · +15.7% YoY
- EBITDA₹231 Cr
Margin 9.7%
- Net Profit₹204 Cr
FY 2025-26 · +180.2% YoY
- P/E (TTM)53.6x
P/B 10.3x
- ROE15.4%
ROCE 18.7%
- Debt / Equity0.10
Interest cover 7.0x
- Employee Count998
Associated legal entities of The Derma Co
The Derma Co operates through Honasa Consumer Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Honasa Consumer Limited Listed CIN L74999DL2016PLC306016 | Active | 16 Sep 2016 | New Delhi, Delhi | ₹2,476 Cr | 864 | 9 | View details |
Board of directors of Honasa Consumer Limited (The Derma Co)
Honasa Consumer Limited is the primary company behind The Derma Co. The board of Honasa Consumer Limited currently have 6 directors; the longest-serving is Varun Alagh, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Varun Alagh DIN 07597289 | Whole-time director | 16 Sep 2016 | 10 yrs 1 mo | Honasa Consumer Limited |
| Ghazal Alagh DIN 07608292 | Whole-time director | 16 Sep 2016 | 10 yrs 1 mo | Honasa Consumer Limited |
| Ishaan Mittal DIN 07948671 | Nominee Director | 03 Jan 2020 | 6 yrs 10 mo | Honasa Consumer Limited |
| Vivek Gambhir DIN 06527810 | Director | 24 Mar 2021 | 5 yrs 7 mo | Honasa Consumer Limited |
| Subramaniam Somasundaram DIN 01494407 | Director | 11 Feb 2022 | 4 yrs 8 mo | Honasa Consumer Limited |
| Namita Gupta DIN 07337772 | Director | 08 Jun 2022 | 4 yrs 5 mo | Honasa Consumer Limited |
IPO & Listings of The Derma Co
The Derma Co is a publicly listed company on the NSE with ticker symbol HONASA in India, operating in the Trading sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: HONASA
- Listed entityHonasa Consumer Limited
- Exchange sectorTrading
Financials of The Derma Co
Exchange-reported figures of Honasa Consumer Limited, the listed company behind The Derma Co (NSE: HONASA).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 2,392 | 2,067 | 1,920 | 1,493 | 943 | 460 |
| Revenue growth | +15.7% | +7.7% | +28.6% | +58.2% | +105.1% | - |
| EBITDA | 231 | 68.53 | 137 | (132) | 11.47 | (1,334) |
| EBITDA margin | +9.7% | +3.3% | +7.1% | -8.8% | +1.2% | -290.0% |
| Profit before tax | 257 | 89.60 | 147 | (141) | 22.44 | (1,325) |
| Net profit | 204 | 72.67 | 113 | 29.08 | 15.74 | (1,332) |
| Net profit margin | +8.5% | +3.5% | +5.9% | +2.0% | +1.7% | -289.6% |
| EPS (βΉ) | 6.12 | 2.24 | 3.45 | (10.47) | 12,088.46 | (9,51,582.14) |
| Balance sheet | ||||||
| Total assets | 1,559 | 1,327 | 1,234 | 704 | 829 | 208 |
| Net worth | 1,412 | 1,180 | 1,095 | 606 | 706 | (1,765) |
| Total debt | 135 | 136 | 131 | 92.19 | 59.63 | 1,954 |
| Cash & bank | 214 | 331 | 486 | 68.06 | 87.69 | 20.75 |
| Net working capital | 173 | 244 | 441 | 110 | 65.78 | 18.09 |
| Cash flow | ||||||
| Cash from operations | 141 | 102 | 235 | (51.55) | 44.59 | 29.73 |
| Cash from investing | (17.06) | (145) | (470) | 39.87 | (505) | (20.61) |
| Cash from financing | (38.03) | (31.11) | 337 | (14.06) | 481 | (1.28) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 731 | 756 | 657 | 602 | 538 | 595 | 534 | 518 |
| Revenue growth (YoY) | +35.9% | +27.0% | +23.2% | +16.2% | +16.5% | +7.4% | - | - |
| Other income | 22.03 | 22.57 | 18.88 | 20.68 | 20.14 | 23.89 | 20.78 | 19.22 |
| EBITDA | 92.92 | 110 | 77.08 | 60.68 | 47.64 | 45.80 | 26.99 | 26.13 |
| EBITDA margin | +12.7% | +14.6% | +11.7% | +10.1% | +8.9% | +7.7% | +5.1% | +5.0% |
| Depreciation | 10.97 | 10.50 | 10.80 | 11.04 | 11.74 | 10.82 | 12.42 | 12.61 |
| Interest | 3.17 | 3.02 | 3.33 | 3.23 | 3.30 | 3.28 | 3.17 | 3.32 |
| Profit before tax | 101 | 119 | 81.83 | 67.09 | 52.74 | 55.59 | 32.18 | 29.42 |
| Tax | 27.55 | 28.80 | 12.40 | 16.88 | 13.52 | 14.27 | 7.19 | 3.39 |
| Net profit | 73.26 | 90.45 | 69.43 | 50.21 | 39.22 | 41.32 | 24.99 | 26.03 |
| EPS (βΉ) | 2.23 | 2.76 | 2.12 | 1.54 | 1.20 | 1.26 | 0.77 | 0.79 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,305 | 2,062 | 1,912 | 1,495 | 932 | 460 | 110 |
| Revenue growth | +11.8% | +7.9% | +27.8% | +60.5% | +102.6% | +319.0% | - |
| EBITDA | 209 | 53.81 | 130 | (108) | 15.62 | (1,334) | (432) |
| EBITDA margin | +9.1% | +2.6% | +6.8% | -7.2% | +1.7% | -290.0% | -393.3% |
| Profit before tax | 245 | 84.13 | 158 | (107) | 27.80 | (1,325) | (428) |
| Net profit | 195 | 64.07 | 121 | 48.00 | 19.87 | (1,332) | (428) |
| Net profit margin | +8.4% | +3.1% | +6.3% | +3.2% | +2.1% | -289.6% | -389.9% |
| EPS (βΉ) | 5.84 | 1.97 | 3.73 | (8.84) | 15,283.08 | (10,24,780.77) | (3,29,250.77) |
| Balance sheet | |||||||
| Total assets | 1,515 | 1,293 | 1,241 | 705 | 762 | 210 | 156 |
| Net worth | 1,396 | 1,173 | 1,124 | 627 | 712 | 189 | 156 |
| Total debt | 109 | 110 | 110 | 73.45 | 44.06 | 20.33 | 0.38 |
| Cash & bank | 190 | 318 | 480 | 53.42 | 78.52 | 20.75 | 26.42 |
| Net working capital | 165 | 234 | 443 | 102 | 54.67 | 19.83 | 30.59 |
| Cash flow | |||||||
| Cash from operations | 119 | 90.34 | 218 | (22.90) | 52.03 | 29.73 | (10.36) |
| Cash from investing | (13.05) | (145) | (459) | 2.96 | (518) | (20.61) | (117) |
| Cash from financing | (29.60) | (24.23) | 344 | (6.63) | 481 | (1.28) | 129 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 689 | 696 | 608 | 587 | 527 | 584 | 523 | 505 |
| Revenue growth (YoY) | +30.9% | +19.3% | +16.3% | +16.4% | +26.2% | +7.4% | - | - |
| Other income | 21.12 | 21.92 | 17.76 | 19.57 | 19.95 | 23.38 | 20.33 | 18.82 |
| Total expenses | 602 | 597 | 539 | 532 | 483 | 542 | 499 | 483 |
| EBITDA | 87.35 | 99.71 | 68.17 | 55.83 | 43.53 | 41.52 | 23.91 | 21.64 |
| EBITDA margin | +12.7% | +14.3% | +11.2% | +9.5% | +8.3% | +7.1% | +4.6% | +4.3% |
| Depreciation | 8.29 | 7.97 | 8.26 | 8.53 | 9.30 | 8.39 | 9.75 | 10.11 |
| Interest | 2.53 | 2.42 | 2.54 | 2.58 | 2.71 | 2.69 | 2.63 | 2.67 |
| Profit before tax | 97.65 | 111 | 75.13 | 64.29 | 51.47 | 53.82 | 31.86 | 27.68 |
| Tax | 25.94 | 26.93 | 10.65 | 16.19 | 13.12 | 13.92 | 7.25 | 2.98 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 731 | 756 | 657 | 602 | 538 | 595 | 534 | 518 |
| Revenue growth (YoY) | +35.9% | +27.0% | +23.2% | +16.2% | +16.5% | +7.4% | - | - |
| Other income | 22.03 | 22.57 | 18.88 | 20.68 | 20.14 | 23.89 | 20.78 | 19.22 |
| EBITDA | 92.92 | 110 | 77.08 | 60.68 | 47.64 | 45.80 | 26.99 | 26.13 |
| EBITDA margin | +12.7% | +14.6% | +11.7% | +10.1% | +8.9% | +7.7% | +5.1% | +5.0% |
| Depreciation | 10.97 | 10.50 | 10.80 | 11.04 | 11.74 | 10.82 | 12.42 | 12.61 |
| Interest | 3.17 | 3.02 | 3.33 | 3.23 | 3.30 | 3.28 | 3.17 | 3.32 |
| Profit before tax | 101 | 119 | 81.83 | 67.09 | 52.74 | 55.59 | 32.18 | 29.42 |
| Tax | 27.55 | 28.80 | 12.40 | 16.88 | 13.52 | 14.27 | 7.19 | 3.39 |
| Net profit | 73.26 | 90.45 | 69.43 | 50.21 | 39.22 | 41.32 | 24.99 | 26.03 |
| EPS (βΉ) | 2.23 | 2.76 | 2.12 | 1.54 | 1.20 | 1.26 | 0.77 | 0.79 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 2,392 | 2,067 | 1,920 | 1,493 | 943 | 460 |
| Revenue growth | +15.7% | +7.7% | +28.6% | +58.2% | +105.1% | - |
| Other income | 83.58 | 78.73 | 49.70 | 22.52 | 20.88 | 12.11 |
| Total expenses | 2,161 | 1,998 | 1,783 | 1,625 | 932 | 1,794 |
| Employee cost | 0.00 | 200 | 171 | 165 | 78.85 | 27.76 |
| EBITDA | 231 | 68.53 | 137 | (132) | 11.47 | (1,334) |
| EBITDA margin | +9.7% | +3.3% | +7.1% | -8.8% | +1.2% | -290.0% |
| Depreciation | 44.40 | 45.01 | 30.62 | 24.96 | 6.90 | 1.71 |
| Interest | 13.14 | 12.65 | 9.04 | 6.66 | 3.01 | 0.98 |
| Profit before tax | 257 | 89.60 | 147 | (141) | 22.44 | (1,325) |
| Tax | 57.07 | 16.93 | 36.60 | 9.93 | 8.00 | 7.61 |
| Net profit | 204 | 72.67 | 113 | 29.08 | 15.74 | (1,332) |
| Net profit margin | +8.5% | +3.5% | +5.9% | +2.0% | +1.7% | -289.6% |
| EPS (βΉ) | 6.12 | 2.24 | 3.45 | (10.47) | 12,088.46 | (9,51,582.14) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 325 | 325 | 324 | 1,929 | 1,793 | 0.03 |
| Reserves & surplus | 1,086 | 855 | 771 | (1,323) | (1,087) | (1,765) |
| Shareholders' funds (net worth) | 1,412 | 1,180 | 1,095 | 606 | 706 | (1,765) |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 135 | 136 | 131 | 92.19 | 59.63 | 1,954 |
| Total debt | 135 | 136 | 131 | 92.19 | 59.63 | 1,954 |
| Total liabilities | 1,559 | 1,327 | 1,234 | 704 | 829 | 208 |
| Assets | ||||||
| Gross block | 637 | 415 | 371 | 305 | 350 | 22.80 |
| Net block | 489 | 302 | 299 | 252 | 342 | 21.09 |
| Capital work in progress | 0.00 | 0.08 | 0.46 | 0.00 | 1.88 | 0.00 |
| Investments | 272 | 305 | 292 | 260 | 339 | 164 |
| Inventories | 179 | 176 | 132 | 121 | 67.14 | 41.35 |
| Sundry debtors | 198 | 132 | 159 | 131 | 72.79 | 33.84 |
| Cash & bank balances | 214 | 331 | 486 | 68.06 | 87.69 | 20.75 |
| Loans & advances | 130 | 84.87 | 68.70 | 70.75 | 37.21 | 14.97 |
| Total current assets | 721 | 725 | 846 | 390 | 265 | 111 |
| Total current liabilities | 548 | 481 | 405 | 281 | 199 | 92.82 |
| Net working capital | 173 | 244 | 441 | 110 | 65.78 | 18.09 |
| Total assets | 1,559 | 1,327 | 1,234 | 704 | 829 | 208 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 32.97 | 107 | 4.65 | 30.39 | 9.76 | 1.92 |
| Net cash from operating activities | 141 | 102 | 235 | (51.55) | 44.59 | 29.73 |
| Net cash from investing activities | (17.06) | (145) | (470) | 39.87 | (505) | (20.61) |
| Net cash from financing activities | (38.03) | (31.11) | 337 | (14.06) | 481 | (1.28) |
| Net change in cash | 86.26 | (74.05) | 102 | (25.74) | 20.63 | 7.84 |
| Closing cash | 214 | 331 | 486 | 68.06 | 87.69 | 20.75 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +15.7% | +7.7% | +28.6% | +58.2% | +105.1% | - |
| EBITDA growth | +237.4% | -50.0% | +203.9% | -1250.2% | +100.9% | - |
| PBT growth | +187.1% | -39.1% | +9998.0% | - | +9998.0% | +9997.0% |
| Net income growth | +180.2% | -35.5% | +287.2% | +84.8% | +101.2% | - |
| Revenue CAGR (3Y) | +17.0% | +29.9% | +61.0% | - | - | - |
| EBITDA CAGR (3Y) | - | +81.5% | - | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +8.4% | +3.5% | +5.8% | -10.1% | +1.5% | -289.6% |
| Return on capital employed | +18.7% | +8.0% | +16.1% | 0.0% | +1.8% | 0.0% |
| Return on net worth | +15.5% | +6.4% | -240.9% | 0.0% | -2.6% | 0.0% |
| Debt / equity | 0.10 | 0.12 | 0.13 | 0.12 | 0.00 | 0.00 |
| Long-term debt / equity | 0.08 | 0.10 | 0.11 | 0.09 | 0.00 | 0.00 |
| Interest cover | 7.03 | 53.78 | 8.49 | -4.25 | 65.86 | -0.07 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 4.55 | 5.26 | 5.68 | 4.56 | 5.06 | 20.18 |
| Inventory turnover | 13.45 | 13.40 | 15.17 | 15.88 | 17.39 | 11.12 |
| Debtors turnover | 14.47 | 14.17 | 13.23 | 14.67 | 17.70 | 13.59 |
| EPS (βΉ) | 6.15 | 2.24 | 3.45 | (10.47) | 12,088.46 | (9,51,582.14) |
| Dividend per share (βΉ) | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 43.39 | 36.28 | 33.78 | (87.07) | (8,36,393.85) | (12,60,824.29) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 689 | 696 | 608 | 587 | 527 | 584 | 523 | 505 |
| Revenue growth (YoY) | +30.9% | +19.3% | +16.3% | +16.4% | +26.2% | +7.4% | - | - |
| Other income | 21.12 | 21.92 | 17.76 | 19.57 | 19.95 | 23.38 | 20.33 | 18.82 |
| Total expenses | 602 | 597 | 539 | 532 | 483 | 542 | 499 | 483 |
| EBITDA | 87.35 | 99.71 | 68.17 | 55.83 | 43.53 | 41.52 | 23.91 | 21.64 |
| EBITDA margin | +12.7% | +14.3% | +11.2% | +9.5% | +8.3% | +7.1% | +4.6% | +4.3% |
| Depreciation | 8.29 | 7.97 | 8.26 | 8.53 | 9.30 | 8.39 | 9.75 | 10.11 |
| Interest | 2.53 | 2.42 | 2.54 | 2.58 | 2.71 | 2.69 | 2.63 | 2.67 |
| Profit before tax | 97.65 | 111 | 75.13 | 64.29 | 51.47 | 53.82 | 31.86 | 27.68 |
| Tax | 25.94 | 26.93 | 10.65 | 16.19 | 13.12 | 13.92 | 7.25 | 2.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,305 | 2,062 | 1,912 | 1,495 | 932 | 460 | 110 |
| Revenue growth | +11.8% | +7.9% | +27.8% | +60.5% | +102.6% | +319.0% | - |
| Other income | 80.66 | 76.37 | 58.34 | 20.44 | 20.68 | 12.11 | 4.38 |
| Total expenses | 2,096 | 2,008 | 1,782 | 1,603 | 916 | 1,794 | 542 |
| Employee cost | 0.00 | 181 | 158 | 125 | 72.03 | 27.76 | 8.90 |
| EBITDA | 209 | 53.81 | 130 | (108) | 15.62 | (1,334) | (432) |
| EBITDA margin | +9.1% | +2.6% | +6.8% | -7.2% | +1.7% | -290.0% | -393.3% |
| Depreciation | 34.48 | 35.52 | 22.87 | 14.78 | 5.65 | 1.71 | 0.65 |
| Interest | 10.53 | 10.53 | 7.19 | 5.06 | 2.85 | 0.98 | 0.05 |
| Profit before tax | 245 | 84.13 | 158 | (107) | 27.80 | (1,325) | (428) |
| Tax | 53.88 | 20.06 | 37.31 | 13.27 | 7.93 | 7.61 | 0.00 |
| Net profit | 195 | 64.07 | 121 | 48.00 | 19.87 | (1,332) | (428) |
| Net profit margin | +8.4% | +3.1% | +6.3% | +3.2% | +2.1% | -289.6% | -389.9% |
| EPS (βΉ) | 5.84 | 1.97 | 3.73 | (8.84) | 15,283.08 | (10,24,780.77) | (3,29,250.77) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 325 | 325 | 324 | 1,929 | 1,793 | 1,954 | 593 |
| Reserves & surplus | 1,071 | 848 | 800 | (1,302) | (1,081) | (1,765) | (437) |
| Shareholders' funds (net worth) | 1,396 | 1,173 | 1,124 | 627 | 712 | 189 | 156 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 109 | 110 | 110 | 73.45 | 44.06 | 20.33 | 0.38 |
| Total debt | 109 | 110 | 110 | 73.45 | 44.06 | 20.33 | 0.38 |
| Total liabilities | 1,515 | 1,293 | 1,241 | 705 | 762 | 210 | 156 |
| Assets | |||||||
| Gross block | 311 | 289 | 206 | 149 | 105 | 22.80 | 1.74 |
| Net block | 188 | 198 | 170 | 126 | 97.75 | 21.09 | 1.01 |
| Capital work in progress | 0.00 | 0.08 | 0.29 | 0.00 | 1.88 | 0.00 | 0.00 |
| Investments | 549 | 391 | 426 | 392 | 532 | 164 | 124 |
| Inventories | 161 | 174 | 124 | 113 | 65.87 | 41.74 | 13.67 |
| Sundry debtors | 196 | 132 | 147 | 114 | 64.77 | 33.84 | 10.61 |
| Cash & bank balances | 190 | 318 | 480 | 53.42 | 78.52 | 20.75 | 26.42 |
| Loans & advances | 124 | 85.92 | 70.38 | 66.06 | 33.11 | 14.97 | 4.62 |
| Total current assets | 671 | 710 | 821 | 346 | 242 | 111 | 55.32 |
| Total current liabilities | 506 | 476 | 378 | 244 | 188 | 91.47 | 24.73 |
| Net working capital | 165 | 234 | 443 | 102 | 54.67 | 19.83 | 30.59 |
| Total assets | 1,515 | 1,293 | 1,241 | 705 | 762 | 210 | 156 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 25.16 | 104 | (1.94) | 24.63 | 9.76 | 1.92 | 0.51 |
| Net cash from operating activities | 119 | 90.34 | 218 | (22.90) | 52.03 | 29.73 | (10.36) |
| Net cash from investing activities | (13.05) | (145) | (459) | 2.96 | (518) | (20.61) | (117) |
| Net cash from financing activities | (29.60) | (24.23) | 344 | (6.63) | 481 | (1.28) | 129 |
| Net change in cash | 76.68 | (78.70) | 103 | (26.56) | 14.87 | 7.84 | 1.41 |
| Closing cash | 190 | 318 | 480 | 53.42 | 78.52 | 20.75 | 26.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +11.8% | +7.9% | +27.8% | +60.5% | +102.6% | +319.0% | - |
| EBITDA growth | +288.5% | -58.6% | +220.5% | -790.6% | +101.2% | -209.0% | - |
| PBT growth | +188.4% | -46.4% | +9998.0% | - | +9998.0% | -209.5% | - |
| Net income growth | +203.6% | -47.0% | +152.0% | +141.6% | +101.5% | -211.2% | - |
| Revenue CAGR (3Y) | +19.7% | +33.8% | +60.8% | +138.8% | +281.1% | - | - |
| EBITDA CAGR (3Y) | - | +50.7% | - | -37.0% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +7.4% | +3.1% | +6.3% | -8.1% | +2.1% | -289.6% | -389.9% |
| Return on capital employed | +18.2% | +7.5% | +17.0% | 0.0% | +2.3% | 0.0% | 0.0% |
| Return on net worth | +14.9% | +6.0% | -581.9% | 0.0% | -3.6% | 0.0% | 0.0% |
| Debt / equity | 0.09 | 0.10 | 0.10 | 0.06 | 0.07 | 0.06 | 0.00 |
| Long-term debt / equity | 0.07 | 0.08 | 0.09 | 0.05 | 0.07 | 0.06 | 0.00 |
| Interest cover | 6.03 | 58.69 | 6.71 | -4.13 | 28.59 | -0.07 | -0.01 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 8.55 | 9.02 | 10.79 | 11.79 | 14.57 | 37.49 | 105.05 |
| Inventory turnover | 15.33 | 14.99 | 16.17 | 16.76 | 17.32 | 16.60 | 14.57 |
| Debtors turnover | 15.63 | 15.99 | 14.64 | 16.70 | 18.90 | 20.70 | 16.57 |
| EPS (βΉ) | 5.86 | 2.12 | 3.73 | (8.84) | 15,283.08 | (10,24,780.77) | (3,29,250.77) |
| Dividend per share (βΉ) | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 42.91 | 36.08 | 34.68 | (85.53) | (8,31,385.38) | (13,57,802.31) | (3,36,284.62) |
Competitors of The Derma Co
The Derma Co has 3 listed competitors in our database, 3 of them funded. They include Foxtale, World of Asaya and Conscious Chemist.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| foxtale.in | 2021 | Mumbai, India | $57.45M | 308 | Online brand of skincare, face, lip, body care, and perfume products | |
| worldofasaya.com | 2021 | Bengaluru, India | $5.73M | Skincare products tailored for darker skin tones are offered online. | ||
| consciouschemist.com | 2019 | Gurugram, India | $2.02M | 39 | Skin care products are offered via an internet-first brand. |
Detailed competitors of The Derma Co
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of The Derma Co
The website of The Derma Co (thedermaco.com) receives about 3M visits a month and ranks #11,340 among all websites worldwide, #506 in Beauty and Cosmetics.
- Monthly visits3M
▼ 32.7% vs previous month
- Unique visitors2.5M
per month
- Global rank#11,340
among all websites
- Category rank#506
Lifestyle · Beauty and Cosmetics
- Bounce rate46%
- Pages per visit4.2
- Average visit1 min 11 sec
- DevicesDesktop 4% Β· Mobile 96%
Websites whose visitors overlap most with The Derma Co. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| beminimalist.co | 100% | 3M | #16,278 | View details | |
| dotandkey.com | 96% | 2.5M | #18,165 | View details | |
| aqualogica.in | 91% | 498.8K | #39,623 | View details | |
| discoverpilgrim.com | 91% | 4.3M | #11,348 | View details | |
| drsheths.com | 89% | 600.8K | #51,763 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for The Derma Co
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as The Derma Co (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Online brand offering mens grooming products | 2015 | Gurugram, Haryana, India | USD 52.66 M | |||
Retailer of perfumes, cosmetics, skincare, and related gift set items | 2012 | Gurugram, Haryana, India | USD 60.63 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about The Derma Co
Complete news archive for The Derma Co
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about The Derma Co
The Derma Co was founded in 2019.
The Derma Co is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
The Derma Co has 998 employees.
The primary company behind The Derma Co, Honasa Consumer Limited, reported revenue of βΉ2,476 Cr for FY 2026, up 16% year on year.
The Derma Co a brand specializing in skin care products, focusing on producing consumer products, providing personal care products, skin care, and products. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
The Derma Co's top competitors include Foxtale, World of Asaya and Conscious Chemist.
Yes, The Derma Co is publicly traded on NSE under the ticker symbol HONASA.
The Derma Co operates through Honasa Consumer Limited.
The legal entities of The Derma Co currently have 8 directors, including Ishaan Mittal, Subramaniam Somasundaram, Varun Alagh and others.
The website of The Derma Co receives about 3 million visits a month and ranks #11,340 among all websites worldwide.
